The number of NK (NK1.1+) tumor infiltrating T cells was also increased in mice bearing shLDH-A B16-F10 tumors compared to those bearing control B16-F10 tumors even without treatment with the PD-1 blocking antibody (Figure 2C). Here, PDCD1 is linked to neoplasm.